KOR

e-Article

Preclinical pharmacologic characterization of GSK2849330, a monoclonal AccretaMab (R) antibody with optimized ADCC and CDC activity directed against HER3
Document Type
Journal
Source
EUROPEAN JOURNAL OF CANCER; NOV 2014, 50 p98-p99, 2p. Supplement: 6
Subject
Language
English
ISSN
18790852